31
Participants
Start Date
December 21, 2012
Primary Completion Date
October 30, 2014
Study Completion Date
June 8, 2015
Omega-3
Patients in this group will receive oral supplementation with EPA+DHA (3.9grams/day) for 6 months.
placebo
Mayo Clinic in Rochester, Rochester
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Building Interdisciplinary Research Careers in Women's Health
UNKNOWN
Mayo Clinic
OTHER